News

Congratulations to ALLG Consumer Representative, Mr John Stubbs AM, who has been appointed a Member of the Order of Australia for ‘significant service to community health, particularly to people [...]

1 January 2023 marks the start of ALLG’s 50th Anniversary year! Since 1973, the ALLG has been conducting clinical trials focused on delivering new treatments and supporting better lives for [...]

An Australian Teletrial Program (ATP) is working to improve access to clinical trials for people living in rural and regional parts of the country. Vesselin Petkov from Cairns [pictured with his [...]

It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

ALLG Member, Dr Ashley Ng, a WEHI Clinical Translational Research Fellow, has been awarded the prestigious Metcalf Prize for Stem Cell Research, for "Controlling rogue blood stem cells".

It's our pleasure to share with you the first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

The ALLG has opened the first hospital site in Australia for a clinical trial that is a world first in acute myeloid leukaemia (AML) trials. The AMLM26 INTERCEPT study aims to radically change [...]

Her Majesty the Queen will be remembered for her devotion and commitment to the Commonwealth for many years to come. We pay tribute to the Queen’s 70 years of service. The Queen’s dedication to [...]

The ALLG trial BM12 CAST has been accepted for publication as an abstract at EHA. Congratulations to the Chief Investigators A/Prof David Curtis and Dr Sushrut Patil, and the trial team.

We are all extremely saddened to announce that our respected colleague and friend Associate Professor James D'Rozario MBBS, FRACP, FRCPA, Senior Staff Specialist and Clinical Director, Department [...]

Clinical trials generate the evidence needed to help close the care gap and improve global practices in cancer care. That’s what we do everyday at the Australasian Leukaemia and Lymphoma Group [...]

A preeminent expert in blood cancer, Professor Mark Hertzberg who has dedicated his life and career to advancing the medicine and science of leukaemia, lymphoma and other blood disorders in [...]

ALLG and HSANZ welcomes the Report tabled in Parliament 25/11/21 on ‘The New Frontier – Delivering better health for all Australians: Inquiry into approval processes for new drugs and novel [...]

Through partnerships and collaborations that we are able to create better treatments and better lives for blood cancer patients.

The Consumer Representative Panel is an invaluable source of information to members of the ALLG

Coming up to the end of the year, we would like to thank Natalia Racomelara and her family for their wonderful support.

The NBCR and Biobank was established by the ALLG in 2012.

Wow, what a year it’s been!

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The European Hematology Association closed its annual congress on Sunday, June 21.

The ALLG is supporting an “EHA Game-Changers” webcast on Thursday, July 2.

The ALLG HD10 clinical trial reached the significant milestone of recruiting 100 patients to this important international cooperative trial.

New research findings on how early genetic changes in blood and bone marrow cells can lead to the development of blood cancer.

Warmest congratulations to Prof Joy Ho and Prof Andrew Roberts, long-time ALLG leaders who were both yesterday appointed Members of the Order of Australia in the Queen’s Birthday Honours.

The ALLG hosted a roundtable discussion yesterday in Melbourne, led by Professor Peter Borchmann of the University of Cologne and co-chairman of the German Hodgkin Study Group (GHSG).

ALLG will take part in Australia’s first Blood Cancer Taskforce, announced yesterday by Minister Greg Hunt and established in collaboration with the Leukaemia Foundation of Australia, which [...]

This week, ALLG’s National Blood Cancer Registry (NBCR) contributed to a new study on acute myeloid leukaemia (AML) published in the Journal of Clinical Oncology.

Cara Markovic joins the ALLG with over 15 years of experience in the medical device industry. A PhD qualified physiologist by training, she has held various scientific and marketing roles in [...]